GIST Registry: Tracking outcomes for people with GIST
Part of Cancer, Digestive system clinical trials.
This study is building a large database of information about people with GIST (gastrointestinal stromal tumors). By joining, you help doctors learn more about the disease and improve care for everyone with GIST.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a gastrointestinal stromal tumor (GIST), a type of tumor that starts in the digestive tract.
- You are willing and able to give permission (informed consent) for the study, both verbally and in writing.
- You are physically and mentally able to understand what the study involves and make a decision about taking part.
- You do not have a severe brain, nerve, or mental health condition that keeps you from giving informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have been taking targeted cancer drugs (called TKIs) for advanced GIST for at least 2 years to understand how these long-term treatments affect quality of life, side effects, and daily living. Researchers want to learn what challenges patients face and how to better support them.
This study is creating a registry to track people with GIST over time. Participating helps researchers learn more about the disease and improve future care.
This trial tests a new drug called NB003 for people with advanced GIST (a type of stomach or intestinal tumor) that has stopped responding to or could not be tolerated after standard treatments like imatinib or sunitinib. The goal is to see if NB003 can help shrink or control the tumor.
This trial studies advanced GIST cancers that have stopped responding to all four standard treatments. It uses PET-CT scans and genetic testing of tumor tissue to understand resistance, helping to find the best next treatment.
This observational study keeps a registry of people diagnosed with gastrointestinal stromal tumor (GIST) to collect real-life information over time. It may help doctors better understand outcomes and care patterns for future patients.
This study looks at how surgery for gastrointestinal stromal tumors (GIST) works, and collects tumor samples to study them under the microscope and by DNA testing. Your results may help researchers better predict tumor behavior and guide future treatment.
Hear when a new Gastrointenstinal Stromal Tumor (GIST) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.